Disease Recurrence and Second Tumors in Long-term Survivors of Lung Cancer;Recidivas y segundos tumores en el cáncer de pulmón de larga supervivencia

Archivos de Bronconeumologia

Volumn 52, Issue 4, 2016, Pages 183-188

  Sánchez de Cos Escuín, Julio ^a   Rodríguez López, David P ^a   Utrabo Delgado, Isabel ^a   Gallego Domínguez, Rocío ^a   Sojo González, M Agustín ^a   Hernández Valle, Manuel ^a  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

Lung cancer; Relapse; Second primary tumors

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURVIVAL; CANCER SURVIVOR; HUMAN; LONG TERM CANCER SURVIVOR; LUNG CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SECOND CANCER; SECOND EXTRAPULMONARY TUMOR; SMOKING; SURVIVAL RATE; ADULT; AGED; FEMALE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; SURVIVOR; TUMOR RECURRENCE; VERY ELDERLY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CONTROLLED STUDY; FOLLOW UP; HIGH RISK POPULATION; LONG TERM SURVIVAL; LUNG SURGERY; SURVIVAL TIME; AGE DISTRIBUTION; METASTASIS; PRIMARY TUMOR; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SURVIVORS;

ANTINEOPLASTIC AGENT;

EID: 85008957344     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2016.02.005     Document Type: Article

References (26)

1. 1 Allemani, C., Weir, H.K., Carreira, H., Harewood, R., Spika, D., Si wang, X., et al. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population based registries in 67 countries (CONCORDE). Lancet, 2014, 62038–62039.
2. 2 Coleman, M.P., Forman, D., Bryant, H., Butjer, J., Rachet, B., Maringe, C., et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweeden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 377 (2011), 127–138.
3. 3 Hollander N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda MD. [consultado 15 Feb 2015]. Disponible en: http://seer.cancer.gov/csr/1975-2011.
4. 4 Sause, W., Kolesar, P., Taylor, S., Johnson, D., Livingston, R., Komaki, R., et al. Final results of phase III trials in regionally advanced unresectable non small cell lung cancer. Chest 117 (2000), 358–364.
5. 5 Van Meerbeeck, J., Kramer, G., van Schil, P.E., Legrand, C., Smit, E.F., Schramel, F.M., et al., EORTC Lung Cancer Group. A randomized trial of radical surgery (RS) versus thoracic radiotherapy (TRT) in patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT). (EORTC 08941). J Clin Oncol, 23(Suppl 16), 2005, 7015.
6. 6 Albain, K.S., Swann, R.S., Rusch, V.R., Turrisi, A.T., Shepherd, F.A., Smith, C.J., et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small cell lung cancer: A phase III randomized controlled trial. Lancet 374 (2009), 379–386.
7. 7 Yu, J.L., Simmons Ch., Victor, J.Ch., Han, D., Hogeveen, S., Leighl, N., et al. Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer. Oncologist 16 (2011), 1307–1315.
8. 8 Martini, N., Bains, M.S., Burt, M.E., Zakowski, M.F., McCormack, P., Rusch, V.W., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995), 120–129.
9. 9 Scott, W.J., Metachronous lung cancer: The role of improved postoperative surveillance. J Thorac Cardiovasc Surg 127 (2004), 633–635.
10. 10 Adenobojo, S.A., Moritz, D.M., Danby Ch, A., The results of modern surgical therapy for multiple primary lung cancers. Chest 112 (1997), 693–701.
11. 11 Kelsey, C.R., Marks, L.B., Hollis, D., Hubbs, J.L., Ready, N.E., D'Amico Th, A., et al. Local recurrence after surgery for early stage lung cancer. An 11-year experience with 975 patients. Cancer 115 (2009), 5218–5227.
12. 12 Aziz, T.M., Saad, R.A., Glasser, J., Jilaihawi, A.N., Prakash, D., The management of second primary lung cancers. A single centre experience in 15 years. Eur J Cardio Thorac Surg. 21 (2002), 527–533.
13. 13 Kawahara, M., Ushijima, S., Kamimori, T., Kodama, N., Ogawara, M., Matsui, K., et al. Second primary tomours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation. Br J Cancer 78 (1998), 409–412.
14. 14 Johnson, B.E., Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 90 (1998), 1335–1345.
15. 15 Duchateau Ch, S.J., Stokkel, M.P.M., Second primary tumors involving non-small cell lung cancer. Chest 127 (2005), 1152–1158.
16. 16 Martini, N., Melamed, N.R., Multiple primary lung cancers. J Thorac Cardiovasc Surg. 70 (1975), 606–612.
17. 17 Detterbeck, F.C., Jones, D.R., Kernstine, K.H., Naunheim, K.S., Special treatment issues. Chest 123 (2003), 244S–258S.
18. 18 Sánchez de Cos Escuín, J., Riesco Miranda, J.A., Antón Martínez, J., Díaz Santamaría, P., Márquez Pérez, L., Medina Gallardo, J.F., et al. Incidencia de carcinoma broncopulmonar en Extremadura durante el año 1998. Arch Bronconeumol. 36 (2000), 381–384.
19. 19 Sánchez de Cos Escuín, J., Miravet, L., Abal, J., Núñez, A., Hernández, J., Castañar, A.M., et al. Estudio multicéntrico epidemiológico-clínico de cáncer de pulmón en España (estudio EpicliCP-2003). Arch Bronconeumol 42 (2006), 446–452.
20. 20 Forman D, Bray F, Brewster DH, Gombe M, Balawa C, Kohler B, et al. Cancer incidence in 5 continents, vol X (electronic version), Lyon, IARC. [consultado 15 Dic 2014]. Disponible en: http://ci5.iarc.fr.
21. 21 Keller, S.M., Vangel, M.G., Wagner, H., Schiller, J., Herskovic, A., Komaki, R., Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer. Lung Cancer 42 (2003), 79–86.
22. 22 Jeremic, B., Shibamato, Y., Acimovic, L., Nikolic, N., Dagovic, A., Aleksandrovic, J., et al. Second cancers occurring in patients with early stage non-small cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 19 (2001), 1056–1063.
23. 23 Slaugther, D.P., Southwick, H.W., Smejkal, W., «Field cancerization» in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6 (1953), 963–968.
24. 24 Braakhuis, B.J.M., Tabor, M.P., Kummer, J.A., Leemans, C.R., Brakenhoff, R.H., A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 63 (2009), 1729–1730.
25. 25 McDonald, S., Haie, Ch., Rubin, Ph., Nelson, D., Divers, L.D., Second malignant tumors in patients with laryngeal carcinoma: Diagnosis, treatment and prevention. Int J Radiat Oncol 17 (1989), 457–465.
26. 26 Carter, B.D., Abnet Ch, C., Feskanich, D., Freedman, N.D., Hartge, P., Lewis, C.E., Smoking and mortality – beyond established causes. N Eng J Med 377 (2015), 631–640.